InVivo Therapeutics reports mixed results from follow-up data on 2 patients implanted with its neuro-spinal scaffold to treat acute spinal cord injury.
Here's a look at some of the top legal news stories for medical device companies this week: Gore ponies up $209m in Bard loss; Siemens, China deny bribery report; InVivo Therapeutics, ex-CEO Reynolds escape shareholders' lawsuit
A federal judge in Boston dismisses a shareholders lawsuit brought against InVivo Therapeutics and ex-CEO Frank Reynolds.
Shares of InVivo Therapeutics are slated to begin trading today on the NASDAQ stock exchange.
InVivo Therapeutics adds the 4th site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.
InVivo Therapeutics adds a 3rd clinical site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.
InVivo Therapeutics readies a 1-for-4 reverse stock split ahead of a planned listing on the NASDAQ stock exchange.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.